ARCHIVES

Bristol-Myers Squibb Board Removes CEO Peter Dolan Over Plavix Deal. Two Republican Senators Say They Will Place Holds On Confirmation of Andrew von Eschenbach as FDA Commissioner. Craig Thompson Named Director of Abramson Cancer Center.

This article is from The Cancer Letter archive.

Vol. 32 No. 32 | September 15, 2006

Download PDF Visit The Full Archive

Related Articles

Bush Budget Reinforces Funding Trends, Reports Say.

July 13, 2001

In Brief: David Tweardy named head of internal medicine at MD Anderson

September 19, 2014

NCI, FDA Are Feuding Again, This Time Overcharge That DCT Moved Too Slowly On Toxicity Notification

April 10, 1981

House Committee Adds $4.1 Billion To HHS Budget, Funds Not Expected To Help NIH.

May 12, 2006

Dana-Farber And Merck To Collaborate On Therapeutics.

February 15, 2008

Promising Areas Of Research Listed By NCAB Subcommittee

February 12, 1982